Data from multiple sources - Curated by Toby Galbraith - Last updated 04 January 2017

Latest news articles

Added 17 days ago Drug news

MorphoSys AG announces Roche plans to initiate a Phase III programme with gantenerumab in patients with prodromal to mild Alzheimer's disease.

MorphoSys AG announced that its partner Roche plans to initiate a new pivotal phase III program for gantenerumab in patients...

Added 23 days ago Drug news

AC Immune SA + Genentech initiate a second Phase III trial for crenezumab to treat Alzheimers disease.

AC Immune SA announced that its partner Genentech, a member of Roche group, has decided to start a second Phase...

Added 1 month ago Drug news

Phase III EPOCH study evaluating MK 8931 (verubecestat) in people with mild-to-moderate Alzheimer’s disease halted- Merck Inc

Merck Inc announced that it will be stopping protocol 017, also known as the EPOCH study, a Phase II/III study...

View all news articles

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

Visit Chronic Lymphocytic Leukaemia (CLL)

Psoriasis

See information on psoriasis pathophysiology, signs and symptoms, comorbidities, treatment options, and more

Visit Psoriasis

Guidelines

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Alzheimer ’s disease and other dementias

Like with the preceding guidelines of this series (Bauer et al. 2002, Bandelow et al. 2008b), these practice guidelines for...

Added 6 years ago

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology

The British Association for Psychopharmacology (BAP) coordinated a meeting of experts to review and revise its first (2006) Guidelines for...

Added 6 years ago

EFNS guidelines for the diagnosis and management of Alzheimer's disease

The aim of this revised international guideline was to present a peer-reviewed evidence-based statement for the guidance of practice for...

Added 7 years ago

View all guidelines

Journal articles

Obesity and Structural Brain Integrity in Older Women: The Women's Health Initiative Magnetic Resonance Imaging Study.

Background: Midlife obesity has been linked to age-related brain atrophy and risk of dementia, but the relationships are less clear...

Added 1 year ago

Insomnia and risk of dementia in older adults: Systematic review and meta-analysis.

There are cross-sectional evidences of an association between sleep disorders and cognitive impairment on older adults. However, there are no...

Added 1 year ago

Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease.

Introduction: As the most common major neurocognitive disorder, Alzheimer's disease (AD) will play an increasingly important role both socially and...

Added 1 year ago

View all journal articles

Clinical trials

ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit

Intensive care unit (ICU) hospitalization saves lives but often does so at a high personal cost to ICU survivors who frequently experience significant cognitive impairment and an array of physical and functional...

Added 11 days ago

View all clinical trials

CME

Case Consults: Changing Paradigms in the Age of Biologics

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
FREE

Treatment Optimisation in Chronic Lymphocytic Leukaemia

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
FREE
View all CME